Reimbursement of pharmaceuticals in New Zealand: comments on PHARMAC's processes.
Swinburn
B
B
The National Heart Foundation, Pharmaceutical Advisory Committee, Auckland. boyds@nhf.org.nz
Milne
R J
RJ
Richards
M
M
Begg
E
E
Foote
S
S
Jackson
R
R
D002317:Cardiovascular Agents / Q000191:economics; D003363:Cost Control; D003362:Cost-Benefit Analysis; D003659:Decision Making, Organizational; D019317:Evidence-Based Medicine; D005252:Fees, Pharmaceutical; D006801:Humans; D007349:Insurance, Health, Reimbursement; D007356:Insurance, Pharmaceutical Services / Q000191:economics*; D009520:New Zealand; D011907:Rate Setting and Review / Q000379:methods* / Q000458:organization & administration; D018570:Risk Assessment
D002317:Cardiovascular Agents